ORKA — ORUKA THERAPEUTICS INC

Ownership history in Commodore Capital LP  ·  6 quarters on record

This page tracks every 13F SEC filing in which Commodore Capital LP reported a position in ORUKA THERAPEUTICS INC (ORKA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
3.54% (2025 Q4)
Avg. % of fund
1.92%
First filed
2024 Q3
Last filed
2025 Q4
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 1,753,054 — 0% 3.54% $53.1M $30.31
2025 Q3 ADDED 1,753,054 +333,340 +23.5% 1.65% $33.7M $19.23
2025 Q2 UNCHANGED 1,419,714 — 0% 1.12% $15.9M $11.21
2025 Q1 UNCHANGED 1,419,714 — 0% 1.07% $14.6M $10.26
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ORKA price (monthly, adj. close)

Other funds also holding ORKA

As of 2025 Q4 — sorted by position size

Remedium Capital Partners, LLC 27.64% Fairmount Funds Management LLC 3Y 8.55% VR Adviser, LLC 3Y 6.21% Avidity Partners Management LP 3Y 5.77% SR ONE CAPITAL MANAGEMENT, LP 3Y 1.85% GREAT POINT PARTNERS LLC 3Y 7Y 1.8% B Group, Inc. 1.68% Synergy Asset Management, LLC 3Y 1.45% Affinity Asset Advisors, LLC 3Y 1.39% Paradigm Biocapital Advisors LP 3Y 1.32%
← Back to Commodore Capital LP Holdings